New Cochrane Review: PSA-based screening likely reduces prostate cancer deaths by about 13% over 23 years, based on data from more than 780,000 men.
In absolute terms, this means about 2 fewer prostate cancer deaths per 1,000 men screened.
doi.org/10.1002/146518…
In absolute terms, this means about 2 fewer prostate cancer deaths per 1,000 men screened.
doi.org/10.1002/146518…